BioRestorative Therapies, Inc. (BRTX)
2.70
+0.03
(+1.12%)
USD |
NASDAQ |
Sep 14, 16:00
2.65
-0.05
(-1.85%)
After-Hours: 18:25
BioRestorative Therapies Enterprise Value : -0.1562M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | -0.1562M |
| September 10, 2026 | -0.0415M |
| September 09, 2026 | -0.067M |
| September 08, 2026 | 0.013M |
| September 04, 2026 | 0.2132M |
| September 03, 2026 | 0.1037M |
| September 02, 2026 | 1.581M |
| September 01, 2026 | 1.494M |
| August 31, 2026 | 1.599M |
| August 28, 2026 | 1.515M |
| August 27, 2026 | 1.691M |
| August 26, 2026 | 1.969M |
| August 25, 2026 | 2.111M |
| August 24, 2026 | 1.874M |
| August 21, 2026 | 1.928M |
| August 20, 2026 | 2.063M |
| August 19, 2026 | 1.877M |
| August 18, 2026 | 1.869M |
| August 17, 2026 | 2.048M |
| August 14, 2026 | 2.198M |
| August 13, 2026 | 2.053M |
| August 12, 2026 | 1.852M |
| August 11, 2026 | 1.793M |
| August 10, 2026 | 1.564M |
| August 07, 2026 | 1.64M |
| Date | Value |
|---|---|
| August 06, 2026 | 1.752M |
| August 05, 2026 | 1.793M |
| August 04, 2026 | 1.793M |
| August 03, 2026 | 1.485M |
| July 31, 2026 | 1.658M |
| July 30, 2026 | 2.188M |
| July 29, 2026 | 2.738M |
| July 28, 2026 | 3.235M |
| July 27, 2026 | 3.500M |
| July 24, 2026 | 3.831M |
| July 23, 2026 | 4.402M |
| July 22, 2026 | 4.519M |
| July 21, 2026 | 4.659M |
| July 20, 2026 | 4.646M |
| July 17, 2026 | 4.955M |
| July 16, 2026 | 5.380M |
| July 15, 2026 | 5.105M |
| July 14, 2026 | 4.850M |
| July 13, 2026 | 5.059M |
| July 10, 2026 | 5.232M |
| July 09, 2026 | 5.220M |
| July 08, 2026 | 5.243M |
| July 07, 2026 | 5.925M |
| July 06, 2026 | 6.527M |
| July 02, 2026 | 6.634M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Myriad Genetics, Inc. | 422.25M |
| CareDx, Inc. | 2.233B |
| Natera, Inc. | 46.39B |
| Exagen, Inc. | 173.15M |
| Sera Prognostics, Inc. | 36.62M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.154M |
| Revenue (Quarterly) | 0.0232M |
| Total Expenses (Quarterly) | 2.178M |
| EPS Diluted (Quarterly) | -2.431 |
| Gross Profit Margin (Quarterly) | -157.8% |
| Profit Margin (Quarterly) | -9.29K% |
| Earnings Yield | -829.7% |
| Normalized Earnings Yield | -967.52 |